KOAN
Resonate Blends, Inc.·Healthcare
0.00
11.111%(+0.00)
Close PriceLast Updated: — ET
52W L: $0.0052W H: $0.02
KOAN NEWS
newsfilecorp.com
6d ago
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in conjunction with the final due diligence being reviewed by MedwellAI, Inc. (OTCQB: MWAI) to acquire Apollo and its subsidiaries including Evolutionary Biologics, Inc. ("Evo Bio"), (the "Transaction"), MWAI has reserved a Preferred Series B class of stock for the share exchanged and assumption of certain liabilities of Apollo. Negotiations are ongoing with certain secured creditors and debtholders of the Company that need to be resolved prior to closing the transaction.
newsfilecorp.com
Feb 10
Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.
North Bergen, New Jersey--(Newsfile Corp. - February 10, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company) is pleased to announce the signing of a Letter of Intent ("LOI") to create a vertically integrated health, wellness and longevity platform. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10533/283349_a912020384f54aed_001full.jpg New MedWell Ai, Inc (OTCQB: MWAI) will be organized across three core divisions: (1) national pharma distribution and telemed platform, (2) nationwide portfolio of premium surgical and cosmetic centers and men's healthcare franchise brand and (3) advanced biologics and product innovation group.
newsfilecorp.com
Feb 6
Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.
North Bergen, New Jersey--(Newsfile Corp. - February 6, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company), announces that the 'Exclusive Distribution Agreement' dated July 1, 2025, between Evolutionary Biologics (a wholly owned subsidiary of Apollo Biowellness) and Revive Regenerative, Inc. ("Revive") has been "terminated for cause" by Evolutionary Biologics, for reasons already disclosed to Revive Regenerative, Inc. and is no longer in effect. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10533/282940_dec73984c4625bd8_001full.jpg The Company will resume management of the distribution and marketing of the Evolutionary Biologics Brands and Products through its own efforts and non-exclusive distribution agreements, while pursuing other opportunities.
